Lonza IPF airway cells

Tuesday, 21 February, 2017 | Supplied by: Lonza Australia Pty Ltd



Lonza now offers cryopreserved lung fibroblasts isolated from donors diagnosed with idiopathic pulmonary fibrosis (IPF) for use in research into this potentially fatal condition. Normal lung fibroblasts and small airway epithelial cells — from both smokers and non-smokers — are also available, offering a complete solution to facilitate IPF and other airway research.

Research into IPF is a rapidly growing field; however, a considerable amount of research is still needed if a cure is to be found, as the pathways of disease progression are not yet understood. Furthermore, IPF tissue has until now been difficult for researchers to source.

By providing IPF cells, Lonza makes it convenient for users to quickly progress with their research. The company’s ability to provide primary cells, coupled with detailed donor information, enables researchers to relate donor characteristics to disease progression.

The IPF cells are available together with normal lung fibroblast cells and culture media, providing a complete cell culture solution for IPF research. In addition, the company has the capability to provide custom isolations where required.

Online: www.lonza.com
Phone: 03 9550 0883
Related Products

BioGX Xfree COVID-19 Direct RT-PCR test

The Xfree COVID-19 Direct RT-PCR test is a complete test in a single vial, lyophilised...

Bio-Rad Laboratories CFX Opus 96 and CFX Opus 384 Real-Time PCR Systems

Bio-Rad Laboratories' CFX Opus 96 and CFX Opus 384 Real-Time PCR Systems are suitable for...

PCR Biosystems NGSBIO Library Quant Kit for Illumina

The kit contains all the components necessary for sensitive quantification of DNA libraries prior...


  • All content Copyright © 2020 Westwick-Farrow Pty Ltd